Search
for
Sort by
Research 121–150 of 1000+
- P165 Real-world experience of ritlecitinib for the treatment of alopecia areata from an alopecia clinic in a large tertiary dermatology centre
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- Clinicoepidemiological profile, precipitating factors and severity indicators in alopecia areata in Manipur
- Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
- An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation
- Excimer Laser: A Module of the Alopecia Areata Common Protocol
- 320 An open label clinical trial of Abatacept (CTLA4-Ig) for alopecia areata
- 368 The Unanticipated Costs, Deficits, and Other Unexpected Burdens in a Diagnosis of Alopecia Areata
- Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations
- SnapshotDx Quiz: September 2018
- Efficacy and safety of Cinainu in paediatric alopecia areata: an international, double-blind, randomized, placebo-controlled, phase II/III trial
- Abstract P5-11-11: A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
- JAK Inhibitor Therapy in Alopecia Areata with Latent Hepatitis B Virus or Tuberculosis Infection: A Safety Assessment
- A Novel Topical Compound Gel Loading Minoxidil and Tofacitinib for Treatment of Alopecia Areata: Formulation, Characterization, and In Vitro/In Vivo Evaluation
- LB943 Tofacitinib treatment of inflammatory skin conditions in patients with Down Syndrome
- Baricitinib in Dermatology: Expanding Therapeutic Horizons Beyond Alopecia Areata
- Management of acne
- Is tapering and stopping of tofacitinib possible among pediatric and adolescent alopecia areata patients?
- O04 Pharmacological efficacy of low-dose oral minoxidil–finasteride combination for hair growth and stability in male androgenetic alopecia: a 12-month retrospective service evaluation
- Acne exacerbation after tofacitinib treatment for alopecia areata
- Acne exacerbation after tofacitinib treatment for alopecia areata
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Baricitinib for the Treatment of Moderate-to-Severe Alopecia Areata
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series
- Safety and Efficacy of Mesotherapy with Placenta Polypeptide Injection for Moderate-to-Severe Sensitive Skin: A Multicenter, Randomized, Controlled Trial
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- Supplementary Figure 2 from Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer
- Effectiveness of oral tofacitinib treatment on patients with moderate‐to‐severe alopecia areata in Iran
- A Pilot Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Tofacitinib Versus Methotrexate In Moderate-to-Severe Alopecia Areata